Related Experiment Video
Updated: Feb 26, 2026
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
2.9K
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case
Etsuko Moriyama1, Hironori Koga1,2, Takashi Niizeki1
1Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Summary
New FP, a hepatic arterial infusion chemotherapy, effectively treated a rare liver malignancy (hepatocellular neoplasm, not otherwise specified) in a young woman, enabling surgical resection and achieving a 20-month disease-free survival.
Area of Science:
- Hepatobiliary Malignancies
- Oncology
- Chemotherapy Research
Background:
- Malignant hepatocellular neoplasm, not otherwise specified (HCN, NOS) is a rare primary liver tumor.
- HCN, NOS presents overlapping features with hepatoblastoma and hepatocellular carcinoma.
- Optimal treatment strategies for HCN, NOS are undefined due to rarity and heterogeneity.
